Top compounds associated with response to CCDC60


Feature Type Standardized
Nominal ANOVA
mRNA cyanoquinoline 11 CTRPv2 pan-cancer AAC 0.13 0.008
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.087 0.009
mRNA lenalidomide GDSC1000 pan-cancer AAC -0.095 0.01
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.091 0.01
mRNA Topotecan CCLE pan-cancer AAC -0.11 0.01
mRNA PLX4720 GDSC1000 pan-cancer AAC -0.08 0.01
mRNA WP1130 CTRPv2 pan-cancer AAC 0.089 0.01
mRNA BRD-K34222889 CTRPv2 pan-cancer AAC 0.079 0.01
mRNA Oxaliplatin CTRPv2 pan-cancer AAC 0.083 0.01
mRNA Gemcitabine CTRPv2 pan-cancer AAC 0.082 0.01
Download CSV